Scientists studying the behavior of platinum particles immersed in hydrogen peroxide may have discovered a new way to propel microscopic machines. The new mechanism is described in The Journal of Chemical Physics, which is produced...
A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment. "Our study investigated how resveratrol and radiotherapy...
A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment. This research, which studied melanoma cells...
When the "war on cancer" was declared with the signing of the National Cancer Act in 1971, identifying potential physical traits, or biomarkers, that would allow doctors to detect the disease early on was a significant goal. To this day, progress...
Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching...
A few desperately ill patients have managed to get into clinical trials at the National Institutes of Health's famed hospital, even though the government's partial shutdown has others being turned away, the agency said Wednesday. Normally, about 200 new patients...
ASCB Executive Director Stefano Bertuzzi, PhD, told reporters that shutting down the driving engines of American bioscientific research, the National Institutes of Health (NIH) and the National Science Foundation (NSF), will have effects well beyond...
CIVCO Announces FDA 510(k) Clearance of Protura™ Robotic Patient Positioning System Integration with Varian Clinac® iX and Trilogy® LinacsOctober 7, 2013 3:42 pm | by PR Newswire | News | Comments
CIVCO Medical Solutions, the leading provider of radiation oncology motion management solutions, is pleased to announce U.S. Food and Drug Administration 510(k) clearance of ProturaTM Robotic Patient Positioning System integration with Varian Medical Systems' Motion Management Interface.
Little Amelia Sloan is a pioneer: Shortly after her birth, scientists took drops of the healthy baby's blood to map her genetic code. Amelia is part of a large research project outside the nation's capital that is decoding the DNA of hundreds of infants.
Massachusetts women's health company Hologic rang in Breast Cancer Awareness Month with the release of registry data from the MammoSite trial, a 7-year study of more than 1,400 patients treated with breast brachytherapy. MammoSite therapy is a breast-conserving treatment that delivers targeted radiation to areas deemed most likely for the re-emergence of cancerous growth.
Cynvenio Announces ClearID, a Breakthrough Test for Monitoring Breast Cancer Patients and Early Detection of RecurrenceOctober 3, 2013 7:30 am | by Business Wire | News | Comments
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.
Nucletron, an Elekta Company, Receives U.S. FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin CancerOctober 2, 2013 12:41 pm | by Bio-Medicine.Org | News | Comments
Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. Esteya is a new approach for high precision skin cancer treatment.
VuCOMP M-Vu® Computer-Aided Detection System for Mammography Installed at Mammography Specialists Medical Group in Los Gatos, CaliforniaOctober 2, 2013 11:44 am | by Business Wire | News | Comments
VuCOMP, Inc. announced today that it has installed its advanced computer-aided detection system, M-Vu CAD, at Mammography Specialists Medical Group (MSMG) in Los Gatos, California. VuCOMP’s CAD system is designed to provide an unprecedented level of performance to help radiologists find breast cancer earlier.
People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant. Tymora Analytical Operations LLC, Purdue University, and St. Jude Children's Research Hospital have been awarded a one-year, $300,000 Phase I STTR grant from the NIH.
Surgical Theater, LLC, creator of the Surgical Rehearsal Platform (SRP), has announced the sale of its cutting-edge technology to The Mount Sinai Hospital, making it the first hospital in New York to utilize the SRP for complicated brain tumor and cerebral-vascular cases.
Researchers are developing a system that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood, an advance that could help medical doctors diagnose cancer earlier than now possible and monitor how well a patient is responding to therapy.
A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells' growth for further analysis. The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide.
Researchers from the University Göttingen Institute of Veterinary Medicine and Chronix Biomedical have published a new study exploring the genetic hallmarks of canine mammary cancer. Appearing in the peer-reviewed journal PLOS ONE, the paper identifies important similarities and differences between human and canine breast tumors, providing a strong platform for future research using the canine model system.
A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies. The group has created an MRI device that could improve both the process and accuracy of breast cancer screening by scanning for sodium levels in the breast.
If you need proof of how information technology is influencing biotech, take a look at Foundation Medicine, the Boston-area diagnostics company that went public on Wednesday. Its stock price quickly doubled after the IPO. And one reason is surely its links to stratospheric tech names from the West Coast.
IMRIS Inc. and Varian Medical Systems today announced that data presented here earlier this week at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality MR images at each treatment session.
Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung CancerSeptember 23, 2013 9:01 am | by The Associated Press | News | Comments
Treating inoperable early-stage non-small cell lung cancer (NSCLC) with a single session of stereotactic body radiation therapy (SBRT) may be a viable option in some cases, according to the results of a multi-institutional randomized phase II trial led by the Radiation Therapy Oncology Group (RTOG) and reported yesterday in a presentation at the 2013 ASTRO Annual Meeting.
Elekta Announces Monaco 5.0 -- Comprehensive Radiation Treatment Planning Capabilities Brought Together in One SystemSeptember 21, 2013 9:22 am | by Bio-Medicine.Org | News | Comments
Elekta today announced Monaco® 5.0, which consolidates support for all of the most clinically useful delivery techniques in a single treatment planning system, and features refinements to planning speed and precision. "This latest Monaco release brings together the best capabilities...
Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein — ASCL1 — is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET.
Researchers at MIT have developed a microfluidic device that mimics the flow of cancer cells through a system of blood vessels. Using high-resolution time-lapse imaging, the researchers captured the moments as a cancer cell squeezes its way through a blood vessel wall into the surrounding extracellular matrix.